Bakul Patel, Senior Policy Advisor, FDA’s Center for Devices and Radiological Health

The growth of healthcare apps is proving a challenge to the Food and Drug Administration. In a new report it says it’s not so worried about the ones that ...

The growth of healthcare apps is proving a challenge to the Food and Drug Administration. In a new report it says it’s not so worried about the ones that help doctors with billing or scheduling or even those that they use to care for patients, such as e-prescription software. But there’s a third category of high-risk devices that regulators are watching closely. Bakul Patel, the senior Policy advisor for the FDA’s Center for Devices and Radiological Health, tells Tom Temin and Emily Kopp on Federal Drive that it’s about function, not form.

Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.

    Getty Images/iStockphoto/SIphotographyretirement

    How to make sure you outlive your investments after you retire

    Read more